Ovarian Cancer Clinical Trial

Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive

Summary

The purpose of this study is to determine whether narrowband imaging (NBI) makes it easier for a surgeon to see cancer.

NBI is a kind of light. Normally, white light is used during surgery. White light uses many wavelengths of light. NBI only uses two wavelengths which highlight the blood vessels. This makes it easier for the surgeon to see blood vessels. Tumors often have more blood vessels than normal tissue. As a result, NBI may make it easier for the surgeon to see small tumors.

In this study the surgeon will look with both normal white light and NBI. This way a comparison can be made to determine which is superior.

Improved identification of tumors allows doctors and patients to make informed decisions about whether treatment is needed after surgery. It also provides additional information to determine which treatments may be best.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients must meet one (or more) of the following criteria:
Preoperative diagnosis of ovarian, fallopian tube, or primary peritoneal carcinoma (all stage, grade and histology)
Preoperative diagnosis of grade III endometrial carcinoma (all stage, all histology)
Preoperative diagnosis of uterine serous carcinoma (all stage, all grade)
Preoperative diagnosis of clear cell endometrial carcinoma (all stage, all grade)
Preoperative diagnosis of endometrial carcinosarcoma (all stage, all grade)
Gastrointestinal carcinoma (all histology, stage and grade)
Pancreatic carcinoma (all histology, stage and grade)
Lung cancer (all histology, stage and grade)
Esophageal carcinoma (all histology, stage and grade)
Suspected or pathologically confirmed metastatic disease to the lung (all disease primaries)
Suspected or pathologically confirmed malignant pleural effusion (all disease primaries)

Patients must meet all of the following criteria:

Planned thorascopic robotic or laparoscopic surgical approach
>18 years old
Not pregnant
Able to give consent Participation in other research protocols does not exclude a patient from participation in this study.

Exclusion Criteria:

None

Study is for people with:

Ovarian Cancer

Estimated Enrollment:

154

Study ID:

NCT01262040

Recruitment Status:

Completed

Sponsor:

Memorial Sloan Kettering Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Memorial Sloan Kettering Cancer Center
New York New York, 10065, United States

How clear is this clinincal trial information?

Study is for people with:

Ovarian Cancer

Estimated Enrollment:

154

Study ID:

NCT01262040

Recruitment Status:

Completed

Sponsor:


Memorial Sloan Kettering Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider